Abstract
Pathogenic variants in mitochondrial aminoacyl-tRNA synthetases result in a broad range of mitochondrial respiratory chain disorders despite their shared role in mitochondrial protein synthesis. LARS2 encodes the mitochondrial leucyl-tRNA synthetase, which attaches leucine to its cognate tRNA. Sequence variants in LARS2 have previously been associated with Perrault syndrome, characterized by premature ovarian failure and hearing loss (OMIM #615300). In this study, we report variants in LARS2 that are associated with a severe multisystem metabolic disorder. The proband was born prematurely with severe lactic acidosis, hydrops, and sideroblastic anemia. She had multisystem complications with hyaline membrane disease, impaired cardiac function, a coagulopathy, pulmonary hypertension, and progressive renal disease and succumbed at 5 days of age. Whole exome sequencing of patient DNA revealed compound heterozygous variants in LARS2 (c.1289C>T; p.Ala430Val and c.1565C>A; p.Thr522Asn). The c.1565C>A (p.Thr522Asn) LARS2 variant has previously been associated with Perrault syndrome and both identified variants are predicted to be damaging (SIFT, PolyPhen). Muscle and liver samples from the proband did not display marked mitochondrial respiratory chain enzyme deficiency. Immunoblotting of patient muscle and liver showed LARS2 levels were reduced in liver and complex I protein levels were reduced in patient muscle and liver. Aminoacylation assays revealed p.Ala430Val LARS2 had an 18-fold loss of catalytic efficiency and p.Thr522Asn a 9-fold loss compared to wild-type LARS2. We suggest that the identified LARS2 variants are responsible for the severe multisystem clinical phenotype seen in this baby and that mutations in LARS2 can result in variable phenotypes.
Keywords
- Premature Ovarian Failure
- Respiratory Chain Complex
- Mitochondrial Protein Synthesis
- Sideroblastic Anemia
- LARS2 Variant
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Competing interests: None declared
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Belostotsky R, Ben-Shalom E, Rinat C et al (2011) Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am J Hum Genet 88:193–200
Bottomley S, Fleming M (2014) Sideroblastic anemia diagnosis and management. Hematol Oncol Clin North Am 28:653–670
Chakraborty P, Schmitz-Abe K, Kennedy E et al (2014) Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD). Blood 124:2867–2871
Dallabona C, Diodato D, Kevelam S et al (2014) Novel (ovario) leukodystrophy related to AARS2 mutations. Neurology 82:2063–2071
Diodato D, Ghezzi D, Tiranti V (2014) The mitochondrial aminoacyl tRNA synthetases: genes and syndromes. Int J Cell Biol 2014:1–11
Du X, Wang ED (2003) E292 is important for the aminoacylation activity of Escherichia coli leucyl-tRNA synthetase. J Protein Chem 22:71–76
Frazier A, Thorburn D (2012) Biochemical analyses of the electron transport chain complexes by spectrophotometry. Methods Mol Biol 837:49–61
Gotz A, Tyynismaa H, Euro L et al (2011) Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet 88:635–642
Konovalova S, Tyynismaa H (2013) Mitochondrial aminoacyl-tRNA synthetases in human disease. Mol Genet Metab 108:206–211
Lue S, Kelley S (2005) An aminoacyl-tRNA synthetase with a defunct editing site. Biochemistry 44:3010–3016
McKenzie M, Lazarou M, Ryan M (2009) Analysis of respiratory chain complex assembly with radiolabeled nuclear- and mitochondrial-encoded subunits. Methods Enzymol 456:321–339
Menezes M, Riley L, Christodoulou J (2014) Mitochondrial respiratory chain disorders in childhood: insights into diagnosis and management in the new era of genomic medicine. Biochim Biophys Acta 1840:1368–1379
Mursinna R, Lincecum T, Martinis S (2001) A conserved threonine within Escherichia coli leucyl-tRNA synthetase prevents hydrolytic editing of leucyl-tRNALeu. Biochemistry 40:5376–5381
Nakajima J, Eminoglu T, Vatansever G et al (2014) A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2. J Hum Genet 59:229–232
Pagliarini DJ, Calvo SE, Chang B et al (2008) A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112–123
Pagnamenta AT, Taanman J-W, Wilson CJ et al (2006) Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod 21:2467–2473
Palencia A, Crépin T, Vu MT, Lincecum TL, Martinis SA, Cusack S (2012) Structural dynamics of the aminoacylation and proofreading functional cycle of bacterial leucyl-tRNA synthetase. Nat Struct Biol 19:677–684
Perret V, Garcia A, Grosjean H, Ebel J, Florentz C, Giege R (1990) Relaxation of transfer RNA specificity by removal of modified nucleotides. Nature 344:787–789
Pierce S, Chisholm K, Lynch E et al (2011) Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci U S A 108:6543–6548
Pierce S, Gersak K, Michaelson-Cohen R et al (2013) Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in Perrrault syndrome. Am J Hum Genet 92:614–620
Riley L, Menezes M, Rudinger-Thirion J et al (2013) Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia. Orphanet J Rare Dis 8:193–203
Sarkar J, Poruri K, Bonieki M, McTavish K, Martinis S (2012) Yeast mitochondrial leucyl-tRNA synthetase CP1 domain has functionally diverged to accommodate RNA splicing at expense of hydrolytic editing. J Biol Chem 287:14722–14781
Schimmel P, Giegé R, Moras D, Yokoyama S (1993) An operational RNA code for amino acids and possible relationship to genetic code. Proc Natl Acad Sci U S A 90:8763–8768
Shahni R, Wedatilake Y, Cleary M, Lindley K, Sibson K, Rahman S (2013) A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations. Am J Med Genet 161:2334–2338
Sohm B, Frugier M, Brule H, Olszak K, Przykorska A, Florentz C (2003) Towards understanding human mitochondrial leucine aminoacylation identity. J Mol Biol 328:995–1010
Starzyk R, Webster T, Schimmel P (1987) Evidence for dispensable sequences inserted into a nucleotide fold. Science 237:1614–1618
Steenweg M, Ghezzi D, Haack T et al (2013) Leukoencephalopathy with thalamus and brainstem involvement and high lactate ‘LTBL’ caused by EARS2 mutations. Brain 135:1387–1394
Talim B, Pyle A, Griffin H et al (2013) Multisystem fatal infantile disease caused by a novel homozygous EARS2 mutation. Brain 136:1–3
Yao Y, Wang L, Wu X, Wang E (2003) Human mitochondrial leucyl-tRNA synthetase with high activity produced from Escherichia coli. Protein Expr Purif 30:112–116
Acknowledgments
We are indebted to Enduo Wang (Shanghai) and Susan Martinis (Urbana) for their generous gifts of clones encoding LARS2 and editing deprived E. coli LARS, respectively. This research was supported by a National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1026891. RLD is an NHMRC Early Career Fellow, DRT is an NHMRC Principal Research Fellow, STC is an NHMRC Career Development Fellow, and CMS is an NHMRC Practitioner Fellow. MDF and KM are supported by RO1 DK 087992 from the US National Institutes of Health. We are grateful to the Crane and Perkins families for their generous financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Carlo Dionisi-Vici, MD
Synopsis (1 Sentence)
LARS2 variants that result in reduced LARS2 aminoacylation activity were identified in a patient with a novel phenotype: hydrops, lactic acidosis, sideroblastic anemia, and multisystem failure.
Compliance with Ethics Guidelines
Conflict of Interest
Lisa G. Riley, Joëlle Rudinger-Thirion, Klaus Schmitz-Abe, David R. Thorburn, Ryan L. Davis, Juliana Teo, Susan Arbuckle, Sandra T. Cooper, Magali Frugier, Kyriacos Markianos Carolyn M. Sue, and Mark D. Fleming declare that they have no conflict of interest.
John Christodoulou is a communicating editor of the Journal of Inherited Metabolic Disease.
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained for all individuals sequenced in the study. This article does not contain any studies with animals.
Author Contributions
LGR performed Sanger sequencing, immunoblotting, and cloning and wrote the manuscript; JR-T and MF designed and performed in vitro aminoacylation assays; KS-A performed WES analysis; DRT provided mitochondrial RC enzyme activities and mtDNA depletion results; RLD and CMS performed mtDNA sequencing and analysis; JT performed bone marrow aspiration and described sideroblastic anemia; SA provided hematology and histopathology images; STC supervised the Western analysis and provided the developmental muscle samples; KM supervised WES analysis and interpretation; MDF and DRC participated in WES analysis and surveyed additional phenotypically similar patients for mutations. JC was involved in the initial diagnosis and management of the patient, obtaining consent and samples for the study, and contributed to the overall conception and progression of the study. All authors contributed to editing the manuscript.
Electronic Supplementary Material
Rights and permissions
Copyright information
© 2015 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Riley, L.G. et al. (2015). LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem Failure. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 28. JIMD Reports, vol 28. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2015_515
Download citation
DOI: https://doi.org/10.1007/8904_2015_515
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-52846-4
Online ISBN: 978-3-662-52847-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)